⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL975187 | 0.83 | — | — | |
| SCHEMBL20764729 | 0.79 | — | — | |
| SCHEMBL415870 | 0.76 | — | — | |
| SCHEMBL43122 | 0.75 | — | — | |
| SCHEMBL5046266 | 0.75 | — | — | |
| SCHEMBL421394 | 0.74 | — | — | |
| SCHEMBL6690391 | 0.69 | — | — | |
| SCHEMBL237001 | 0.67 | — | — | |
| SCHEMBL1012959 | 0.67 | — | — | |
| SCHEMBL417863 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15766 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399209-A1 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH (DE) | 2024-07-17 | — | — | EP | claimed |
| US-20240217968-A1 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2024-07-04 | — | — | US | claimed |
| EP-4384177-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2024115465-A1 | PHARMACEUTICAL COMPOUNDS AS PARP7 AND/OR PARP1 INHIBITORS | Duke Street Bio Limited (GB) | 2024-06-06 | — | — | WO | claimed |
| CN-117957223-A | Quinoline derivatives | 礼蓝动物保健有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117897159-A | Heterocyclic compounds and methods of use | 安进公司 | 2024-04-16 | — | — | CN | claimed |
| EP-4313300-A1 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2024-02-07 | — | — | EP | claimed |
| WO-2023239709-A2 | TARGETING AN ENZYME REQUIRED FOR ACUTE MYELOID LEUKEMIA | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2023-12-14 | — | — | WO | claimed |
| CN-111943890-B | Pharmaceutical compounds | 艾欧米制药有限公司 | 2023-10-31 | — | — | CN | claimed |
| WO-2023156386-A2 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2023-08-24 | — | — | WO | claimed |
| WO-1986000072-A1 | HERBICIDAL 2-ARYL-1,2,4-TRIAZINE-3,5(2H,4H)-DIONES AND SULFUR ANALOGS THEREOF | FMC CORPORATION (US) | 1986-01-03 | — | — | WO | claimed |
| EP-0161304-A1 | HERBICIDAL 1-ARYL-4-SUBSTITUTED-1,4-DIHYDRO-5H-TETRAZOL-5-ONES AND SULFUR ANALOGS THEREOF. | FMC CORP (US) | 1985-11-21 | — | — | EP | claimed |
| EP-0157876-A1 | HERBICIDAL 1-ARYL-$g(D)?2 -1,2,4-TRIAZOLIN-5-ONES | FMC Corporation (US) | 1985-10-16 | — | — | EP | claimed |
| WO-1985001939-A1 | HERBICIDAL 1-ARYL-4-SUBSTITUTED-1,4-DIHYDRO-5H-TETRAZOL-5-ONES AND SULFUR ANALOGS THEREOF | FMC CORPORATION (US) | 1985-05-09 | — | — | WO | claimed |
| WO-1985001637-A1 | HERBICIDAL 1-ARYL-DELTA2-1,2,4-TRIAZOLIN-5-ONES | FMC CORPORATION (US) | 1985-04-25 | — | — | WO | claimed |
| EP-0130025-A1 | 2-Alkylthiopenem derivatives | PFIZER INC. (US) | 1985-01-02 | — | — | EP | claimed |
| EP-0075808-A2 | 3,6-Dioxo-1,2-dihydro-7H-pyrazolo(3,4-b)pyridine dyes | BAYER AG (DE) | 1983-04-06 | — | — | EP | claimed |
| US-4260776-A | PYRAZOLONE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-07 | — | — | US | claimed |
| US-4186129-A | CENTRAL NERVOUS SYSTEM DEPRESSANTS, ANTICONVULSANTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-01-29 | — | — | US | claimed |
| US-4000123-A | POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | claimed |